BioMarin (BMRN) Mentioned As Takeover Target

TheStreet.com columnist Marc Lichtenfeld mentions BioMarin (Nasdaq: BMRN) as an attractive acquisition candidate. Karen Andersen, an analyst with Morningstar, speculated that Genzyme (Nasdaq: GENZ) could be interested.

According to the report, the CEO said he opposes the idea of a takeover, but does acknowledge that they cannot remain independent forever. Link